These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30574801)

  • 1. Effects of long-term administration of Lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation.
    Riezzo G; Chimienti G; Orlando A; D'Attoma B; Clemente C; Russo F
    Benef Microbes; 2019 Mar; 10(2):137-147. PubMed ID: 30574801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.
    Riezzo G; Orlando A; D'Attoma B; Linsalata M; Martulli M; Russo F
    Benef Microbes; 2018 Jan; 9(1):51-60. PubMed ID: 29022390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.
    Ojetti V; Ianiro G; Tortora A; D'Angelo G; Di Rienzo TA; Bibbò S; Migneco A; Gasbarrini A
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):387-91. PubMed ID: 25531996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial.
    Kubota M; Ito K; Tomimoto K; Kanazaki M; Tsukiyama K; Kubota A; Kuroki H; Fujita M; Vandenplas Y
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levels.
    Fisher PM; Holst KK; Adamsen D; Klein AB; Frokjaer VG; Jensen PS; Svarer C; Gillings N; Baare WF; Mikkelsen JD; Knudsen GM
    Hum Brain Mapp; 2015 Jan; 36(1):313-23. PubMed ID: 25220079
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    García Contreras AA; Vásquez Garibay EM; Sánchez Ramírez CA; Fafutis Morris M; Delgado Rizo V
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus Reuteri DSM 17938
    Saviano A; Brigida M; Migneco A; Gunawardena G; Zanza C; Candelli M; Franceschi F; Ojetti V
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34201542
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.
    Klein AB; Trajkovska V; Erritzoe D; Haugbol S; Madsen J; Baaré W; Aznar S; Knudsen GM
    J Cereb Blood Flow Metab; 2010 Nov; 30(11):e1-7. PubMed ID: 20736957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans.
    Bhang S; Ahn JH; Choi SW
    J Affect Disord; 2011 Feb; 128(3):299-304. PubMed ID: 20674984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypes do not confer risk for delinquency but rather alter susceptibility to positive and negative environmental factors: gene-environmentinteractions of BDNF Val66Met, 5-HTTLPR, and MAOA-uVNTR [corrected].
    Nilsson KW; Comasco E; Hodgins S; Oreland L; Åslund C
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.
    Wegner A; Banaszkiewicz A; Kierkus J; Landowski P; Korlatowicz-Bilar A; Wiecek S; Kwiecien J; Gawronska A; Dembinski L; Czaja-Bulsa G; Socha P
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):494-500. PubMed ID: 29650440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial.
    Indrio F; Di Mauro A; Riezzo G; Civardi E; Intini C; Corvaglia L; Ballardini E; Bisceglia M; Cinquetti M; Brazzoduro E; Del Vecchio A; Tafuri S; Francavilla R
    JAMA Pediatr; 2014 Mar; 168(3):228-33. PubMed ID: 24424513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Benefit of Lactobacillus reuteri DSM 17938 as an Addition to the Treatment of Functional Constipation.
    Jadrešin O; Sila S; Trivić I; Mišak Z; Hojsak I; Kolaček S
    J Pediatr Gastroenterol Nutr; 2018 Dec; 67(6):763-766. PubMed ID: 30134331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of BDNF Val66Met and serotonin transporter 5-HTTLPR polymorphisms on psychopathological characteristics in a sample of university students.
    Kourmouli N; Samakouri M; Mamatsiou A; Trypsianis G; Livaditis M; Veletza S
    Psychiatr Genet; 2013 Oct; 23(5):188-97. PubMed ID: 23884433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of childhood trauma on serum BDNF in bipolar depression is modulated by the serotonin promoter genotype.
    Benedetti F; Ambrée O; Locatelli C; Lorenzi C; Poletti S; Colombo C; Arolt V
    Neurosci Lett; 2017 Aug; 656():177-181. PubMed ID: 28754344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.
    Aguilera M; Arias B; Wichers M; Barrantes-Vidal N; Moya J; Villa H; van Os J; Ibáñez MI; Ruipérez MA; Ortet G; Fañanás L
    Psychol Med; 2009 Sep; 39(9):1425-32. PubMed ID: 19215635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study.
    Buchmann AF; Hellweg R; Rietschel M; Treutlein J; Witt SH; Zimmermann US; Schmidt MH; Esser G; Banaschewski T; Laucht M; Deuschle M
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):902-9. PubMed ID: 23058261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
    Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
    Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.